These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

746 related items for PubMed ID: 23932644

  • 1. Novel effects of the cannabinoid inverse agonist AM 251 on parameters related to metabolic syndrome in obese Zucker rats.
    Merroun I, Sánchez-González C, Martínez R, López-Chaves C, Porres JM, Aranda P, Llopis J, Galisteo M, Zarzuelo A, Errami M, López-Jurado M.
    Metabolism; 2013 Nov; 62(11):1641-50. PubMed ID: 23932644
    [Abstract] [Full Text] [Related]

  • 2. Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats.
    Vickers SP, Webster LJ, Wyatt A, Dourish CT, Kennett GA.
    Psychopharmacology (Berl); 2003 Apr; 167(1):103-11. PubMed ID: 12632249
    [Abstract] [Full Text] [Related]

  • 3. The cannabinoid CB1 receptor antagonist SR141716A (Rimonabant) enhances the metabolic benefits of long-term treatment with oleoylethanolamide in Zucker rats.
    Serrano A, Del Arco I, Javier Pavón F, Macías M, Perez-Valero V, Rodríguez de Fonseca F.
    Neuropharmacology; 2008 Jan; 54(1):226-34. PubMed ID: 17467748
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Blockade of cannabinoid CB1 receptors improves renal function, metabolic profile, and increased survival of obese Zucker rats.
    Janiak P, Poirier B, Bidouard JP, Cadrouvele C, Pierre F, Gouraud L, Barbosa I, Dedio J, Maffrand JP, Le Fur G, O'Connor S, Herbert JM.
    Kidney Int; 2007 Dec; 72(11):1345-57. PubMed ID: 17882151
    [Abstract] [Full Text] [Related]

  • 6. Antidiabetic effects of sub-chronic administration of the cannabinoid receptor (CB1) antagonist, AM251, in obese diabetic (ob/ob) mice.
    Irwin N, Hunter K, Frizzell N, Flatt PR.
    Eur J Pharmacol; 2008 Feb 26; 581(1-2):226-33. PubMed ID: 18191122
    [Abstract] [Full Text] [Related]

  • 7. Central versus peripheral antagonism of cannabinoid CB1 receptor in obesity: effects of LH-21, a peripherally acting neutral cannabinoid receptor antagonist, in Zucker rats.
    Pavón FJ, Serrano A, Pérez-Valero V, Jagerovic N, Hernández-Folgado L, Bermúdez-Silva FJ, Macías M, Goya P, de Fonseca FR.
    J Neuroendocrinol; 2008 May 26; 20 Suppl 1():116-23. PubMed ID: 18426510
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Diazoxide enhances basal metabolic rate and fat oxidation in obese Zucker rats.
    Alemzadeh R, Karlstad MD, Tushaus K, Buchholz M.
    Metabolism; 2008 Nov 26; 57(11):1597-607. PubMed ID: 18940400
    [Abstract] [Full Text] [Related]

  • 11. Expression of the cannabinoid system in muscle: effects of a high-fat diet and CB1 receptor blockade.
    Crespillo A, Suárez J, Bermúdez-Silva FJ, Rivera P, Vida M, Alonso M, Palomino A, Lucena MA, Serrano A, Pérez-Martín M, Macias M, Fernández-Llébrez P, Rodríguez de Fonseca F.
    Biochem J; 2011 Jan 01; 433(1):175-85. PubMed ID: 20955176
    [Abstract] [Full Text] [Related]

  • 12. The cannabinoid CB1 receptor inverse agonist, rimonabant, modifies body weight and adiponectin function in diet-induced obese rats as a consequence of reduced food intake.
    Thornton-Jones ZD, Kennett GA, Benwell KR, Revell DF, Misra A, Sellwood DM, Vickers SP, Clifton PG.
    Pharmacol Biochem Behav; 2006 Jun 01; 84(2):353-9. PubMed ID: 16814374
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A novel peripheral cannabinoid receptor 1 antagonist, BPR0912, reduces weight independently of food intake and modulates thermogenesis.
    Hsiao WC, Shia KS, Wang YT, Yeh YN, Chang CP, Lin Y, Chen PH, Wu CH, Chao YS, Hung MS.
    Diabetes Obes Metab; 2015 May 01; 17(5):495-504. PubMed ID: 25656402
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of independent and combined chronic metabolic effects of GIP and CB1 receptor blockade in high-fat fed mice.
    Irwin N, Hunter K, Flatt PR.
    Peptides; 2008 Jun 01; 29(6):1036-41. PubMed ID: 18291559
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Diet-dependent modulation of hippocampal expression of endocannabinoid signaling-related proteins in cannabinoid antagonist-treated obese rats.
    Rivera P, Luque-Rojas MJ, Pastor A, Blanco E, Pavón FJ, Serrano A, Crespillo A, Vida M, Grondona JM, Cifuentes M, Bermúdez-Silva FJ, de la Torre R, de Fonseca FR, Suárez J.
    Eur J Neurosci; 2013 Jan 01; 37(1):105-17. PubMed ID: 23033907
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.